Source comparison
TB-500 Research Pregnancy: [Peptide Type] Comparison
The table below compares TB-500 against other research peptides commonly used in tissue repair and regenerative studies, focusing on reproductive safety profiles, placental transfer data, and washout requirements. TB-500 (Thymosin Beta-4 Fragment) Actin-bindin
This comparison does not assign a generated winner or score.
- The table below compares TB-500 against other research peptides commonly used in tissue repair and regenerative studies, focusing on reproductive safety profiles, placental transfer data, and washout requirements.
- TB-500 (Thymosin Beta-4 Fragment)
- Actin-binding; promotes cell migration and angiogenesis
- Yes. Detected in fetal tissue in animal studies
- None in humans; limited animal data
- Minimum 90 days before conception attempts
- High concern due to actin modulation during organogenesis and confirmed barrier crossing
- BPC-157 (Body Protection Compound)
- Promotes angiogenesis via VEGF pathway; gastric cytoprotection
- Unknown. No published studies on placental transfer
- None in humans or animals
- 60–90 days (precautionary)
- Moderate concern due to angiogenic activity; lacks reproductive data entirely
- GHK-Cu (Copper Peptide)
- Collagen synthesis stimulation; antioxidant activity
- Copper crosses placenta; peptide transfer unconfirmed
- Limited safety data; copper toxicity at high doses is documented
- 30–60 days
- Moderate concern due to copper component; lower molecular weight may increase transfer risk
- Epithalon (Epitalon)
- Telomerase activation; pineal gland regulation
- Unknown. No reproductive studies exist
- None
- 60 days (precautionary)
- Low to moderate concern; mechanism doesn't directly impact embryogenesis but lacks all safety data
- Melanotan II
- Melanocortin receptor agonist; affects pigmentation and libido
- Unknown. Suspected due to lipophilic structure
- None; anecdotal reports of use during pregnancy exist but unverified
- 90 days minimum
- High concern due to hormonal activity and unknown fetal impact on melanocortin signaling